BioRem Inc. (TSXV:BRM)
Canada flag Canada · Delayed Price · Currency is CAD
3.870
+0.100 (2.65%)
Aug 10, 2026, 3:59 PM EST

BioRem Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
50.742.3637.4225.1728.8624.48
Revenue Growth
32.16%13.19%48.69%-12.81%17.91%0.42%
Cost of Revenue
35.2929.5927.3618.1420.118.24
Gross Profit
15.4112.7710.067.028.766.24
Selling, General & Admin
6.996.145.623.915.793.91
Research & Development
0.10.050.040.030.10.01
Other Operating Expenses
-0.180.080.050.020.240.24
Total Operating Expenses
6.916.285.713.966.124.17
Operating Income
8.386.494.343.062.642.07
Interest Expense
-0.15-0.16-0.2-0.27-0.26-0.04
Total Non-Operating Income (Expense)
-0.15-0.16-0.2-0.27-0.26-0.04
Pretax Income
8.236.334.152.792.382.03
Provision for Income Taxes
2.021.511.10.610.770.74
Net Income
6.224.823.042.181.611.3
Net Income to Common
6.224.823.042.181.611.3
Net Income Growth
97.71%58.25%39.66%35.11%24.34%-37.89%
Shares Outstanding (Basic)
161616161536
Shares Outstanding (Diluted)
191919171837
Shares Change
-0.30%-0.40%9.40%-2.55%-53.08%-5.32%
EPS (Basic)
0.390.300.190.140.100.04
EPS (Diluted)
0.330.260.160.130.090.03
EPS Growth
98.32%62.50%23.08%41.48%164.97%-30.64%
Free Cash Flow
0.017.273.31-0.061.243.71
Free Cash Flow Growth
-99.78%119.45%---66.50%23.48%
Free Cash Flow Per Share
0.000.390.18-0.000.070.10
Gross Margin
30.40%30.14%26.87%27.90%30.36%25.48%
Operating Margin
16.53%15.32%11.61%12.17%9.15%8.46%
Profit Margin
12.26%11.37%8.13%8.66%5.59%5.30%
FCF Margin
0.02%17.17%8.85%-0.25%4.30%15.14%
EBITDA
8.86.964.823.452.992.41
EBITDA Margin
17.35%16.44%12.87%13.69%10.36%9.86%
EBIT
8.386.494.343.062.642.07
EBIT Margin
16.53%15.32%11.61%12.17%9.15%8.46%
Effective Tax Rate
24.48%23.89%26.63%21.86%32.32%36.23%